EquatorVision

EQUATΘR is an international collaboration bringing together world leaders from the field of clinical uveitis, image analysis, and outcome methodology.

[ASTUTE Trial @AstuteTrial]

Introducing the ASTUTE trial, sponsored by @uhbwNHS - a randomised controlled trial looking at #adalimumab for the treatment of #autoimmune #uveitis. The trial is in set up and we look forward to bringing you more news soon! Follow us to stay up to date. @andrewdick4 @Abby_OCon

[UveitisCSG @UveitisCSG]

Uveitis CSG guidance on #uveitis patients during #COVID19 pandemic.

Created in partnership with paed+adult rheumatologists, NHSE for a unified cross-disciplinary response.

https://t.co/axx3qmLI12

[The Lancet Rheumatology @TheLancetRheum]

Tocilizumab in patients with anti-TNF refractory juvenile idiopathic #arthritis-associated #uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial https://t.co/vK7eCQ3a4d #LancetRheumatology #OpenAccess #JIA @VersusArthritis

[Fight for Sight @fightforsightUK]

We've convened the UK’s leading ophthalmologists to draw attention to the ‘1:20 funding gap’ in eye research. A public letter published in today’s Guardian, calls on the new government to develop a national plan on sight loss. Read more here 👉 https://t.co/8PqflGXTwj

[Dr Lola Solebo 💙👶🏾👁️👩🏾‍💻 @lolaeyedoc]

Many children with #uveitis can’t tell when things are active - that’s why eye checks in #JIA are so important - but some children & young people CAN feel it. Please help us shine a light on this🕵🏾‍♀️Thank you ⁦@OliviasVision⁩ & ⁦@JIA_Matters⁩!

[Dr Tas Braithwaite @tasbraithwaite]

We are thrilled to share today that @fightforsightUK and @BirdshotCharity are funding our research to develop novel AI imaging tools for Birdshot #uveitis Go team! @Denniston_Ophth @pearsekeane @crabblab and thank you! @OliviasVision

[Fight for Sight @fightforsightUK]

Your generosity has enabled us to fund important new research into birdshot uveitis. https://t.co/NhDzt6x00T

[CochraneEyes @CochraneEyes]

New #Cochrane Review looking at anti-tumour necrosis factor drugs for macular oedema due to #uveitis.
https://t.co/wNWUxZHWcM
@OliviasVision @UveitisCruces

[Crabb Lab Research @crabblab]

Important new research in @AmJOphthalmol shows #glaucoma patients with #uveitis have faster visual field loss than those without
https://t.co/7tL5WdMavk
@TweetIGA @OliviasVision
Congrats 2 authors @DrXiaoLiu Stephen Kelly @GiovMontesano @Suzie_R_B @pearsekeane @Denniston_Ophth

[OrphanetJournal at BMC @ojrarediseases]

Under-utilization of reproducible, child appropriate or patient reported outcome measures in childhood uveitis interventional research, reviewed in OJRD #RareDisease https://t.co/CY2QPzNi49

[Dr Tas Braithwaite @tasbraithwaite]

What a lovely live illustration of all that the Birdshot Uveitis Society are achieving for their patients! @waeh

[Crabb Lab Research @crabblab]

Congratulations to @crabblab researchers @g_ometto, @GiovMontesano & Pete Jones for an excellent paper in @ARVOtvst on ReLayer, a free online tool to segment #OCT images. Well done team! @Ismail_Moghul @npontikos @pearsekeane @DrXiaoLiu @Denniston_Ophth https://t.co/vo36VnMLjv

[Dr Tas Braithwaite @tasbraithwaite]

This weekend ICD-11 has been officially presented to Member States at the 2019 World Health Assembly. I hope the added granularity in the ICD-11 definitions for vision impairment better guides the data we need to impact avoidable vision loss globally https://t.co/tFAr0b92Du

[Ophthalmology at BMJ @BMJ_Ophth]

Uncertainty amongst #uveitis specialists on the management of childhood non-infectious chronic anterior uveitis in the UK. This study highlights the need for research to improve outcomes and provide evidence based medicine @lolaeyedoc. https://t.co/Oqqtj7OOet

[Alastair Denniston @Denniston_Ophth]

@EquatorVision An important milestone in moving the care of patients with #uveitis to the modern era. We're aiming to replace traditional clinician guesstimates with measures that are sensitive, objective and reliable. Thanks Gary for your vision and hard work.

[EquatorVision @EquatorVision]

Thank you to Dr Gary Holland and the committee for putting this fantastically productive workshop #uveitis #clinicaltrials

[EquatorVision @EquatorVision]

@DrXiaoLiu talks about developing an automated OCT-based method for quantifying vitreous haze @UCLA @NatEyeInstitute @US_FDA #uveitis endpoints workshop

[EquatorVision @EquatorVision]

@lolaeyedoc presenting her study of AC inflammation in children with #uveitis

[EquatorVision @EquatorVision]

Tom McNally summarises the evidence on instrument based measures of AC flare and aqueous proteins at #uveitis endpoints workshop